- Home
- VIVK vs ENLV Comparison
VIVK vs ENLV Comparison
Compare VIVK & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVK
- ENLV
- Stock Information
- Founded
- VIVK 2006
- ENLV 2005
- Country
- VIVK United States
- ENLV Israel
- Employees
- VIVK N/A
- ENLV N/A
- Industry
- VIVK Oilfield Services/Equipment
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- VIVK Energy
- ENLV Health Care
- Exchange
- VIVK Nasdaq
- ENLV Nasdaq
- Market Cap
- VIVK 25.6M
- ENLV 26.6M
- IPO Year
- VIVK N/A
- ENLV 1995
- Fundamental
- Price
- VIVK $0.17
- ENLV $1.00
- Analyst Decision
- VIVK
- ENLV Strong Buy
- Analyst Count
- VIVK 0
- ENLV 2
- Target Price
- VIVK N/A
- ENLV $10.00
- AVG Volume (30 Days)
- VIVK 85.3M
- ENLV 155.0K
- Earning Date
- VIVK 11-20-2025
- ENLV 11-28-2025
- Dividend Yield
- VIVK N/A
- ENLV N/A
- EPS Growth
- VIVK N/A
- ENLV N/A
- EPS
- VIVK N/A
- ENLV N/A
- Revenue
- VIVK $124,048,464.00
- ENLV N/A
- Revenue This Year
- VIVK N/A
- ENLV N/A
- Revenue Next Year
- VIVK N/A
- ENLV N/A
- P/E Ratio
- VIVK N/A
- ENLV N/A
- Revenue Growth
- VIVK 98.83
- ENLV N/A
- 52 Week Low
- VIVK $0.17
- ENLV $0.81
- 52 Week High
- VIVK $1.68
- ENLV $2.10
- Technical
- Relative Strength Index (RSI)
- VIVK 32.64
- ENLV 36.86
- Support Level
- VIVK $0.20
- ENLV $0.98
- Resistance Level
- VIVK $0.36
- ENLV $1.07
- Average True Range (ATR)
- VIVK 0.06
- ENLV 0.04
- MACD
- VIVK 0.01
- ENLV -0.01
- Stochastic Oscillator
- VIVK 3.40
- ENLV 11.11
About VIVK Vivakor Inc.
Vivakor Inc is a socially responsible operator, acquirer and developer of technologies and assets in the oil and gas industry, as well as related environmental solutions. It is focused on operating crude oil gathering, storage and transportation facilities, as well as contaminated soil remediation services. Company have two operating business segments: Transportation logistics services; Terminaling and storage facility product and services related to oil and gas production. Majority of revenue is from Terminaling and storage segment.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.